Name
Osaühing Mai Apteek
Registry code
10020618
VAT number
EE100138542
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
29.03.1996 (28)
Financial year
01.01-31.12
Capital
25 830.00 €
Activity
47731 - Dispensing chemist in specialised stores
1 346 445 €
-2 166 €
-0%
2 213 €
(estimate is approximate)
13 086 €
5
Submitted
No tax arrears
-17%
-1%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Omanikukonto: MARIT VAHER 27.07.1979 (45) | 51% - 13 045.00 EUR | Board member | Indirect ownership | |
| Financium OÜ 11902013 | 50% - 12 785.00 EUR | - | - | |
| Andres Kaljo 04.05.1983 (41) | - | - | Indirect ownership |
| 2019 01.04.2020 | 2020 31.05.2021 | 2021 27.05.2022 | 2022 30.06.2023 | 2023 30.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 2 046 287 € | 1 930 925 € | 1 475 426 € | 1 407 341 € | 1 346 445 € |
| Net profit (loss) for the period | 1 700 € | 15 615 € | 37 902 € | 61 064 € | -2 166 € |
| Profit Margin | 0% | 1% | 3% | 4% | -0% |
| Current Assets | 526 136 € | 397 332 € | 435 271 € | 262 281 € | 223 385 € |
| Fixed Assets | 184 415 € | 171 754 € | 163 389 € | 1 512 € | 10 494 € |
| Total Assets | 710 551 € | 569 086 € | 598 660 € | 263 793 € | 233 879 € |
| Current Liabilities | 242 361 € | 107 788 € | 133 547 € | 191 123 € | 181 448 € |
| Non Current Liabilities | 0 € | 0 € | 0 € | 57 417 € | 39 345 € |
| Total Liabilities | - | - | - | 248 540 € | 220 793 € |
| Share Capital | - | - | - | - | - |
| Equity | 468 190 € | 461 298 € | 465 113 € | 15 253 € | 13 086 € |
| Employees | 12 | 8 | 6 | 6 | 5 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 321 342.53 € | 20 209.57 € | 18 744.25 € | 5 |
| 2023 Q4 | 350 968.19 € | 26 452.51 € | 22 773.24 € | 6 |
| 2023 Q3 | 312 271.53 € | 18 148.42 € | 12 922.41 € | 6 |
| 2023 Q2 | 346 018.29 € | 20 801.65 € | 16 804.02 € | 5 |
| 2023 Q1 | 356 906.54 € | 20 988.29 € | 17 481.32 € | 6 |
| 2022 Q4 | 369 630.97 € | 20 707.74 € | 15 429.69 € | 6 |
| 2022 Q3 | 305 401.45 € | 23 104.12 € | 21 226.16 € | 5 |
| 2022 Q2 | 363 876.73 € | 29 529.09 € | 20 050.21 € | 4 |
| 2022 Q1 | 353 088.28 € | 31 767.41 € | 19 272.18 € | 6 |
| 2021 Q4 | 426 411 € | 34 392.7 € | 22 655.6 € | 8 |
| 2021 Q3 | 347 140.38 € | 27 519.86 € | 19 848.03 € | 7 |
| 2021 Q2 | 361 903 € | 29 333.99 € | 19 912.77 € | 7 |
| 2021 Q1 | 343 149.69 € | 32 204.65 € | 21 222.13 € | 8 |
| 2020 Q4 | 437 129.22 € | 37 752.39 € | 21 892.89 € | 8 |
| 2020 Q3 | 478 137.54 € | 36 054.58 € | 24 524.72 € | 8 |
| 2020 Q2 | 545 416.33 € | 39 441.2 € | 26 829.54 € | 9 |
| 2020 Q1 | 584 998.71 € | 52 594.83 € | 39 660.65 € | 12 |
